MenA Is a Promising Drug Target for Developing Novel Lead Molecules to Combat Mycobacterium tuberculosis

E-ISSN： 1875-6638|5|2|197-207

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.5, Iss.2, 2009-03, pp. : 197-207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Purine Metabolism in Mycobacterium tuberculosis as a Target for Drug Development

Current Pharmaceutical Design, Vol. 13, Iss. 6, 2007-02 ,pp. : 599-608

Bentham Science Publishers

Access to resources Recommend Favorite

Mycobacterium tuberculosis DNA Gyrase as a Target for Drug Discovery

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 7, Iss. 2, 2007-01 ,pp. : 159-168

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Modern InhA Inhibitors to Combat Drug Resistant Strains of Mycobacterium tuberculosis

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 5, 2007-03 ,pp. : 489-498

Bentham Science Publishers

Access to resources Recommend Favorite

Vitamins Based Novel Target Pathways/Molecules as Possible Emerging Drug Targets for the Management of Tuberculosis

Medicinal Chemistry, Vol. 14, Iss. 3, 2018-04 ,pp. : 212-224

Bentham Science Publishers

Access to resources Recommend Favorite

Peptide deformylase – a promising therapeutic target for tuberculosis and antibacterial drug discovery

By Sharma Anshika Khuller Gopal K Sharma Sadhna

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 7, 2009-07 ,pp. : 753-765

Informa Healthcare

Access to resources Recommend Favorite